Works matching DE "DOXAZOSIN"

Results: 225

Perioperative Blood Pressure Control in Pheochromocytoma: The Role of Intravenous Urapidil.

Published in:

Endocrinology Research & Practice, 2024, v. 28, n. 2, p. 133, doi. 10.5152/erp.2024.23378

By:

Tural, Egemen;
Özsarı, Levent

Publication type:

Article

Pharmacokinetics of Doxazosin Gastrointestinal Therapeutic System after Multiple Administration in Korean Healthy Volunteers.

Published in:

Drug Development & Industrial Pharmacy, 2007, v. 33, n. 8, p. 824, doi. 10.1080/03639040601012999

By:

Kwon, Yoon Hee;
Gwak, Hye Sun;
Yoon, Sun Jung;
Chun, In Koo

Publication type:

Article

Bioequivalence Evaluation of Two Formulations of Doxazosin Tablet in Healthy Thai Male Volunteers.

Published in:

Drug Development & Industrial Pharmacy, 2005, v. 31, n. 10, p. 1035, doi. 10.1080/03639040500306328

By:

Sripalakit, Pattana;
Nermhom, Penporn;
Maphanta, Sirada;
Polnok, Sangla;
Jianmongkol, Poj;
Saraphanchotiwitthaya, Aurasorn

Publication type:

Article

Administration-Time-Dependent Effects of Doxazosin GITS on Ambulatory Blood Pressure of Hypertensive Subjects.

Published in:

Chronobiology International: The Journal of Biological & Medical Rhythm Research, 2004, v. 21, n. 2, p. 277, doi. 10.1081/CBI-120037772

By:

Hermida, Ramón C.;
Calvo, Carlos;
Ayala, Diana E.;
Domínguez, María J.;
Covelo, Manuel;
Fernández, José R.;
Fontao, María J.;
López, José E.

Publication type:

Article

Tolerability of alpha-Blockade With Doxazosin as a Therapeutic Option for Symptomatic Benign...

Published in:

Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 1998, v. 53A, n. 3, p. M201, doi. 10.1093/gerona/53A.3.M201

By:

Kaplan, Steven A.;
Alisera, Patricia Meade D'

Publication type:

Article

Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.

Published in:

BJU International, 2006, v. 97, n. 1, p. 90, doi. 10.1111/j.1464-410X.2006.05858.x

By:

Byung Ha Chung;
Sung Joon Hong

Publication type:

Article

Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.

Published in:

2005

By:

Anastasios A. Athanasopoulos;
Perimenis, Petros S.

Publication type:

Letter

Back to the future for urological drug development?

Published in:

BJU International, 2005, v. 95, n. 6, p. 899, doi. 10.1111/j.1464-410X.2005.05424.x

By:

Wyllie, Michael G.

Publication type:

Article

The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.

Published in:

BJU International, 2005, v. 95, n. 4, p. 575, doi. 10.1111/j.1464-410X.2005.05342.x

By:

Fitzpatrick, John M.;
Desgrandchamps, François

Publication type:

Article

Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects.

Published in:

BJU International, 2004, v. 94, n. 9, p. 1263, doi. 10.1111/j.1464-410X.2004.05154.x

By:

MacDonald, Roderick;
Wilt, Timothy J.;
Howe, R. William

Publication type:

Article

Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.

Published in:

BJU International, 2004, v. 94, n. 6, p. 817, doi. 10.1111/j.1464-410X.2004.05039.x

By:

Lee, Ji Youl;
Kim, Hyun Woo;
Lee, Seung Ju;
Koh, Jun Sung;
Suh, Hong Jin;
Chancellor, Michael B.

Publication type:

Article

Comparative efficacy of two α<sub>1</sub>-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.

Published in:

BJU International, 2004, v. 93, n. 6, p. 757, doi. 10.1111/j.1464-410X.2003.04720.x

By:

De Reijke, T. M.;
Klarskov, P.

Publication type:

Article

Prostate apoptosis after doxazosin treatment in the spontaneous hypertensive rat model.

Published in:

BJU International, 2004, v. 93, n. 3, p. 410, doi. 10.1111/j.1464-410X.2003.04627.x

By:

Lujan, M.;
Ferruelo, A.;
Paez, A.;
Moreno, A.;
Berenguer, A.

Publication type:

Article

Doxazosin and finasteride alone or in combination: the PREDICT study.

Published in:

BJU International, 2003, v. 91, n. 7, p. 591, doi. 10.1046/j.1464-410X.2003.04214.x

By:

Lynch, T.H.

Publication type:

Article

A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasia.

Published in:

BJU International, 2003, v. 91, n. 1, p. 41, doi. 10.1046/j.1464-410X.2003.03077.x

By:

Kirby, R.S.

Publication type:

Article

A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia.

Published in:

BJU International, 2001, v. 87, n. 3, p. 192, doi. 10.1046/j.1464-410X.2001.02032.x

By:

Kirby, R.S.;
Andersen, M.;
Gratzke, P.;
Dahlstrand, C.;
Høye, K.

Publication type:

Article

Does the time of administration (morning or evening) affect the tolerability or efficacy of tamsulosin?

Published in:

BJU International, 2001, v. 87, n. 1, p. 31, doi. 10.1046/j.1464-410X.2001.00984.x

By:

Michel, M.C.;
Neumann, H.G.;
Mehlburger, L.;
Schumacher, H.;
Goepel, M.

Publication type:

Article

Doxazosin: a new cytotoxic agent for prostate cancer?

Published in:

BJU International, 2000, v. 85, n. 6, p. 672, doi. 10.1046/j.1464-410X.2000.00607.x

By:

Cal, C.;
Uslu, R.;
Gunaydin, G.;
Ozyurt, C.;
Omay, S.B.

Publication type:

Article

Adenoviral-bone morphogenetic protein-7 and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model.

Published in:

Molecular Medicine Reports, 2017, v. 16, n. 6, p. 9431, doi. 10.3892/mmr.2017.7785

By:

CERVANTES-GARCIA, DANIEL;
CUELLAR-JUAREZ, ADRIANA GUADALUPE;
BORREGO-SOTO, GISSELA;
ROJAS-MARTINEZ, AUGUSTO;
ALDABA-MURUATO, LISETH RUBI;
SALINAS, EVA;
VENTURA-JUAREZ, JAVIER;
MUÑOZ-ORTEGA, MARTIN HUMBERTO

Publication type:

Article

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

Published in:: 2000
Publication type:: journal article

HEALTH AGENCIES UPDATE.

Published in:

JAMA: Journal of the American Medical Association, 2000, v. 283, n. 15, p. 1950

By:

Stephenson, Joan

Publication type:

Article

A Specific High-Performance Thin-Layer Chromatography with Fluorescence Detection for the Determination of Some α 1 -Blockers.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2015, v. 38, n. 2, p. 271, doi. 10.1080/10826076.2014.903852

By:

Mohamed, NiveenA.;
Ahmed, Sameh;
El Zohny, SallyA.

Publication type:

Article

An unusual adrenal cause of hypoglycaemia.

Published in:

2017

By:

O'Toole, S. M.;
Turner, B. C.;
Plowman, P. N.;
Batterham, R. L.;
Drake, W. M.

Publication type:

Case Study

Differential effects of urapidil and doxazosin on heart rate.

Published in:

European Journal of Clinical Pharmacology, 2007, v. 63, n. 3, p. 259, doi. 10.1007/s00228-006-0256-2

By:

Stoschitzky, Kurt;
Stoschitzky, Gergana;
Wonisch, Manfred;
Brussee, Helmut

Publication type:

Article

Doxazosin reduces cell proliferation and increases collagen fibers in rat prostatic lobes.

Published in:

Cell & Tissue Research, 2008, v. 332, n. 1, p. 171, doi. 10.1007/s00441-007-0559-3

By:

Justulin, Luis;
Delella, Flavia;
Felisbino, Sérgio

Publication type:

Article

HYPERTENSION: EXPERIMENTAL.

Published in:: Nephrology Dialysis Transplantation, 2014, v. 29, n. suppl_3, p. iii61, doi. 10.1093/ndt/gfu137
Publication type:: Article

Assessment of Frailty and Association With Progression of Benign Prostatic Hyperplasia Symptoms and Serious Adverse Events Among Men Using Drug Therapy.

Published in:

JAMA Network Open, 2021, v. 4, n. 11, p. e2134427, doi. 10.1001/jamanetworkopen.2021.34427

By:

Bauer, Scott R.;
Walter, Louise C.;
Ensrud, Kristine E.;
Suskind, Anne M.;
Newman, John C.;
Ricke, William A.;
Liu, Teresa T.;
McVary, Kevin T.;
Covinsky, Kenneth

Publication type:

Article

Homologous recombination induced by doxazosin mesylate and saw palmetto in the Drosophila wing-spot test.

Published in:

Journal of Applied Toxicology, 2013, v. 33, n. 3, p. 209, doi. 10.1002/jat.1740

By:

Gabriel, Katiane Cella;
Dihl, Rafael Rodrigues;
Lehmann, Mauricio;
Reguly, Maria Luiza;
Richter, Marc François;
Andrade, Heloisa Helena Rodrigues

Publication type:

Article

Diurnal exposure profile in rats from dietary administration of a chemical (doxazosin) with a short half-life: interplay of age and diurnal feeding pattern

Published in:

Journal of Applied Toxicology, 1992, v. 12, n. 1, p. 7

By:

Monro, A. M.;
Charuel, C.;
Comby, P.

Publication type:

Article

Insulin resistance impairs response to doxazosin therapy in men with benign prostatic hyperplasia.

Published in:

Turkish Journal of Medical Sciences, 2013, v. 43, n. 1, p. 1, doi. 10.3906/sag-1203-90

By:

GÖKKAYA, Cevdet Serkan;
ÖZTEKİN, Çetin Volkan;
ÖZDEN, Cüneyt;
ÖZTÜRK, Emin;
AKTAŞ, Binhan Kağan;
MEMİŞ, Ali

Publication type:

Article

Doxazosin attenuates renal matrix remodeling mediated by anti-α<sub>1</sub>-adrenergic receptor antibody in a rat model of diabetes mellitus.

Published in:

Experimental & Therapeutic Medicine, 2017, v. 14, n. 3, p. 2543, doi. 10.3892/etm.2017.4827

By:

LIN-SHUANG ZHAO;
YAN-YAN LIN;
YI LIU;
CHUN-YAN XU;
YE LIU;
WEI-WEI BAI;
XUE-YING TAN;
DE-ZHONG LI;
JIN-LING XU

Publication type:

Article

Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.

Published in:

Clinical Hemorheology & Microcirculation, 1999, v. 20, n. 1, p. 57

By:

Toth;
Nemes;
Czopf;
Kapronczay;
Kesmarky;
Juricskay

Publication type:

Article

Orally applied doxazosin disturbed testosterone homeostasis and changed the transcriptional profile of steroidogenic machinery, cAMP/cGMP signalling and adrenergic receptors in Leydig cells of adult rats.

Published in:

Andrology, 2013, v. 1, n. 2, p. 332, doi. 10.1111/j.2047-2927.2012.00035.x

By:

Stojkov, N. J.;
Janjic, M. M.;
Kostic, T. S.;
Andric, S. A.

Publication type:

Article

Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy.

Published in:

International Journal of Impotence Research, 2002, v. 14, n. 1, p. 50, doi. 10.1038/sj.ijir.3900815

By:

De Rose, A.F.;
Giglio, M.;
Traverso, P.;
Lantieri, P.;
Carminani, G.

Publication type:

Article

Podium 5 - Therapy.

Published in:

International Journal of Impotence Research, 2001, v. 13, n. 5, p. S31, doi. 10.1038/sj.ijir.3900750

By:

De Rose, A.F.;
Giglio, M.;
Traverso, P.;
Corbu, C.;
Carmignani, G.;
Hatzichristou, D.;
Apostolidis, A.;
Bekos, A.;
Tzortzis, V.;
Ioannidis, E.;
Yannakoyorgos, K.;
Montorsi, F.;
Heaton, J.;
Sleep, D.;
Perdok, R.;
Rescek, M.E.;
Padma-Nathan, H.;
Rosen, R.C.;
Shabsigh, R.

Publication type:

Article

Acute intoxication with doxazosin.

Published in:

Human & Experimental Toxicology, 2005, v. 24, n. 6, p. 337, doi. 10.1191/0960327105ht531oa

By:

Satar, Salim;
Sebe, Ahmet;
Avci, Akkan;
Yesilagac, Hasan;
Gokel, Yuksel

Publication type:

Article

Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion.

Published in:

Gut & Liver, 2016, v. 10, n. 1, p. 101, doi. 10.5009/gnl14459

By:

Muñoz-Ortega, Martin Humberto;
Llamas-Ramírez, Raúl Wiliberto;
Romero-Delgadillo, Norma Isabel;
Elías-Flores, Tania Guadalupe;
Tavares-Rodríguez, Edgar de Jesus;
del Rosario Campos-Esparza, María;
Cervantes-García, Daniel;
Muñoz-Fernández, Luis;
Gerardo-Rodríguez, Martin;
Ventura-Juárez, Javier

Publication type:

Article

Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis.

Published in:

Gut & Liver, 2016, v. 10, n. 1, p. 10, doi. 10.5009/gnl15576

By:

Yong-Han Paik

Publication type:

Article

Effects of Î±1-Adrenoceptor Antagonists on Male Sexual Function.

Published in:

Drugs, 2006, v. 66, n. 3, p. 287, doi. 10.2165/00003495-200666030-00002

By:

van Dijk, Marleen M;
de la Rosette, Jean J M C H;
Michel, Martin C

Publication type:

Article

Doxazosin Gastrointestinal Therapeutic System: A Review of its Use in Benign Prostatic Hyperplasia.

Published in:

Drugs, 2005, v. 65, n. 14, p. 2037, doi. 10.2165/00003495-200565140-00008

By:

Goldsmith, David R.;
Plosker, Greg L.

Publication type:

Article

Evaluation of the effect of sildenafil and/or doxazosin on Benign prostatic hyperplasia-related lower urinary tract symptoms and erectile dysfunction.

Published in:

Urology Annals, 2013, v. 5, n. 4, p. 237, doi. 10.4103/0974-7796.120293

By:

Abolyosr, Ahmed;
ElSagheer, Gamal A.;
Abdel-Kader, Mohammad S.;
Hassan, Ahmed M.;
Abou-Zeid, Abdel-Monem M.

Publication type:

Article

Sex-Specific Effects of AGT-6 and ACE I/D on Pulse Pressure After 6 Months on Antihypertensive Treatment: The GenHAT Study.

Published in:

Annals of Human Genetics, 2007, v. 71, n. 6, p. 735, doi. 10.1111/j.1469-1809.2007.00381.x

By:

Lynch, A. I.;
Arnett, D. K.;
Davis, B. R.;
Boerwinkle, E.;
Ford, C. E.;
Eckfeldt, J. H.;
Leiendecker-Foster, C.

Publication type:

Article

Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro.

Published in:

Platelets, 2002, v. 13, n. 5/6, p. 267, doi. 10.1080/0953770021000007203

By:

Alarayyed, N.A.;
Prichard, B.N.C.;
Betteridge, D.J.;
Smith, C.C.T.

Publication type:

Article

Matrix Metalloproteinase-2, -9 and Tissue Inhibitor Metalloproteinase-1 in Patients with Hypertension Before and After Doxazosin Therapy.

Published in:

High Blood Pressure & Cardiovascular Prevention, 2006, v. 13, n. 3, p. 47, doi. 10.2165/00151642-200613020-00002

By:

Derosa, Giuseppe;
Cicero, Arrigo F. G.;
D'Angelo, Angela;
Tinelli, Carmine;
Ciccarelli, Leonardina;
Piccinni, Mario N.;
Pricolo, Fabio;
Salvadeo, Sibilla;
Montagna, Lorenza;
Fogari, Elena;
Gravina, Alessia;
Ferrari, Ilaria;
Galli, Simona;
Paniga, Sonia;
Fogari, Roberto

Publication type:

Article

Matrix Metalloproteinase-2, -9 and Tissue Inhibitor Metalloproteinase-1 in Patients with Hypertension Before and After Doxazosin Therapy.

Published in:

High Blood Pressure & Cardiovascular Prevention, 2006, v. 13, n. 2, p. 47, doi. 10.2165/00151642-200613020-00002

By:

Derosa, Giuseppe;
Cicero, Arrigo F. G.;
D'Angelo, Angela;
Tinelli, Carmine;
Ciccarelli, Leonardina;
Piccinni, Mario N.;
Pricolo, Fabio;
Salvadeo, Sibilla;
Montagna, Lorenza;
Fogari, Elena;
Gravina, Alessia;
Ferrari, Ilaria;
Galli, Simona;
Paniga, Sonia;
Fogari, Roberto

Publication type:

Article

BPH management sees continual evolution and innovation.

Published in:: 2020
Publication type:: Proceeding

5-ARI treatment linked to decline in sexual function.

Published in:

Urology Times, 2014, v. 42, n. 10, p. 14

By:

Krader, Cheryl Guttman

Publication type:

Article

Rewriting the script on polypharmacy.

Published in:

2017

By:

Hickner, John

Publication type:

Editorial

Resistant hypertension? Time to consider this fourth-line drug.

Published in:

Journal of Family Practice, 2016, v. 65, n. 4, p. 266

By:

Kaysin, Alexander;
Mounsey, Anne

Publication type:

Article

Doxazosin and Carvedilol Treatment Improves Hepatic Regeneration in a Hamster Model of Cirrhosis.

Published in:

BioMed Research International, 2018, p. 1, doi. 10.1155/2018/4706976

By:

Serna-Salas, Sandra Alejandra;
Navarro-González, Yesenia Danyeli;
Martínez-Hernández, Sandra Luz;
Barba-Gallardo, Luis Fernando;
Sánchez-Alemán, Esperanza;
Aldaba-Muruato, Liseth Rubí;
Macías-Pérez, José Roberto;
Ventura-Juárez, Javier;
Muñoz-Ortega, Martin Humberto

Publication type:

Article